ROSEN, NATIONAL TRIAL LAWYERS, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR

NEW YORK, Dec. 2, 2022/PRNewswire/ --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) between March 10, 2021 and October 4, 2022, both dates inclusive (the "Class Period"), of the important January 9, 2023lead plaintiff deadline.SO WHAT: If you purchased Eiger securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.WHAT TO DO NEXT: To join the Eiger class action, go to https://rosenlegal.com/submit-form/?case_id=9654 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 9, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.